1 completed, 1 recruiting, 1 unknown, 1 withdrawn. 4 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 4 | Completed 1, Recruiting 1, Unknown 1, Withdrawn 1 |
Follow Cardiac Event: new trials by email Literature Review of Cardiac Event trials Research Report on Cardiac Event
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Comparison of Clopidogrel-based Antiplatelet Agent Treatment and Aspirin Plus Low Dose Rivaroxaban Therapy Aspirin and low-dose rivaroxaban, Clopidogrel with or without aspirin - Cardiac Event, Coronary Artery Disease | Phase 4 | Recruiting | Seoul National University Bundang Hospital | 2758 | 2023-11-15 | 2026-09-02 |
| The Effectiveness and Safety of Levosimendan in Patients With Severe Aortic Stenosis and Heart Failure Undergoing Transcatheter Aortic Valve Replacement Levosimendan, Placebo - Aortic Valve Stenosis, Heart Failure | Phase 4 | Unknown | China National Center for Cardiovascular Diseases | 124 | 2020-09-01 | 2020-10-05 |
| Intraoperative Insulin Administration at Cardiac Surgery for Diabetic Patients Fast-acting human insulin - Diabetes Mellitus, Cardiac Event | Phase 4 | Completed | The Hashemite University | 70 | 2019-06-01 | 2021-04-01 |
| Cardiac Safety of Lansoprazole and Domperidon Combination Lansoprazole/Domperidone, Lansoprazole - GERD, Cardiac Event | Phase 4 | Withdrawn | Neutec Ar-Ge San ve Tic A.Ş | 2018-03-01 | 2023-01-05 |
Cardiovascular Diseases (4) · Aortic Valve Stenosis (1) · Coronary Artery Disease (1) · Diabetes Mellitus (1) · Diabetes Mellitus, Type 2 (1) · Gastroesophageal Reflux (1) · Heart Failure (1) · Hemorrhage (1) · Insulin Resistance (1) · Peripheral Arterial Disease (1)
Heart Diseases (2) · Aortic Valve Disease (1) · Arterial Occlusive Diseases (1) · Arteriosclerosis (1) · Atherosclerosis (1) · Coronary Disease (1) · Deglutition Disorders (1) · Digestive System Diseases (1) · Endocrine System Diseases (1) · Esophageal Diseases (1) · Esophageal Motility Disorders (1) · Gastrointestinal Diseases (1) · Glucose Metabolism Disorders (1) · Heart Valve Diseases (1) · Hyperinsulinism (1)
2'-deoxythymidylyl-(3'-5')-2'-deoxyadenosine (1) · Aspirin (1) · BID protein, human (1) · Clopidogrel (1) · Domperidone (1) · Insulin (1) · Lansoprazole (1) · Rivaroxaban (1) · Simendan (1)
China National Center for Cardiovascular Diseases (1) · Neutec Ar-Ge San ve Tic A.Ş (1) · Seoul National University Bundang Hospital (1) · The Hashemite University (1)
China (1) · Jordan (1) · South Korea (1) · Turkey (Türkiye) (1)
In-Ho Chae, M.D Ph.D (1) · Mohanad M Odeh, PhD (1) · Serhat Bor, Prof Dr (1)